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Abstract
Objective: Natriuretic peptide receptor-C (NPR-C/NPR-3) is a cell surface protein involved in vascular
remodelling that is up-regulated in atherosclerosis. NPR-C expression has not been well characterized in human
carotid artery occlusive lesions. We hypothesized that NPR-C expression correlates with intimal features of
vulnerable atherosclerotic carotid artery plaque.
Methods: To test this hypothesis, we evaluated NPR-C expression by immunohistochemistry (IHC) in carotid
endarterectomy (CEA) specimens isolated from 18 patients. The grade, location, and co-localization of NPR-C in
CEA specimens were evaluated using two tissue analysis techniques.
Results: Relative to minimally diseased CEA specimens, we observed avid NPR-C tissue staining in the intima of
maximally diseased CEA specimens (65%; p=0.06). Specifically, maximally diseased CEA specimens demonstrated
increased NPR-C expression in the superficial intima (61%, p=0.17), and deep intima (138% increase; p=0.05). In
the superficial intima, NPR-C expression significantly co-localized with vascular smooth muscle cells (VSMCs) and
macrophages. The intensity of NPR-C expression was also higher in the superficial intima plaque shoulder and cap
regions, and significantly correlated with atheroma and fibroatheroma vulnerable plaque regions (β=1.04, 95%
CI=0.46, 1.64).
Conclusion: These findings demonstrate significant NPR-C expression in the intima of advanced carotid artery
plaques. Furthermore, NPR-C expression was higher in vulnerable carotid plaque intimal regions, and correlate with
features of advanced disease. Our findings suggest that NPR-C may serve as a potential biomarker for carotid
plaque vulnerability and progression, in patients with advanced carotid artery occlusive disease.
Keywords: Natriuretic peptide receptor-C; Carotid; Atherosclerosis;
Arterial intima; Plaque biomarker; Plaque vulnerability; Stroke
Introduction
Nearly 20% of all ischemic strokes result from an atherosclerotic
embolic source located at the extra-cranial carotid artery bifurcation in
the mid-neck region [1]. More than 95% of patients with high-grade
atherosclerotic carotid artery stenosis are asymptomatic [2-4]. It is
unclear what subset of patients have a vulnerable atherosclerotic
carotid lesion that can lead to a stroke [4,5]. This is a significant
diagnostic and management dilemma, and to date there are no
molecular markers of carotid atherosclerotic disease progression that
could help identify higher risk patients that may benefit from early
clinical intervention [6].
Natriuretic peptide receptor-C (NPR-C; NPR3), and its ligand C-
type natriuretic peptide (CNP), are expressed in the vasculature [7,8],
and are involved in cellular proliferation [9,10], migration [11], and
vascular remodeling [12]. Following ligand binding, NPR-C activates
cell signal transduction via guanine nucleotide regulatory protein
activation and downstream MAP kinase and phospholipase-C
signaling [13,14]. These pathways affect a wide variety of cell specific
functions such as vascular smooth muscle cell (VSMC)
hyperpolarization and relaxation [15], and inhibition of L-type
calcium currents in cardiac myocytes [16]. These findings thereby
implicate NPR-C in the regulation of vascular homeostatic functions
and potentiation of atherosclerotic disease.
Previously, NPR-C was identified to be highly expressed by
neointimal VSMCs in fibroatheromatous coronary plaques [17], and
VSMCs in coronary atherectomy specimens [12]. In these studies, as
well as others, the expression of NPR-C and its ligand CNP appear to
correlate with the severity of atherosclerotic disease [8,18,19].
Histopathology and gene expression analysis of coronary artery
atheromas further demonstrate that NPR-C expression is highest in the
intima and inner media layers of intermediate plaques [9,12,17]. A
recent study also observed NPR-C expression in carotid artery media
[20]. However, it remains unclear whether NPR-C expression is also
altered in the carotid artery intima, and whether its expression pattern
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correlates with features of advanced carotid artery atherosclerotic
occlusive disease. We hypothesized that similar to the coronary
vasculature [8,17], and carotid media [20], NPR-C expression is
increased in the carotid intima of advanced atheromas, and correlates
with features of plaque vulnerability. To test this, we evaluated NPR-C
expression by immunohistochemistry (IHC) in maximally and
minimally diseased carotid endarterectomy (CEA) plaque specimens.
Masked observation and statistical modeling was used to determine
whether NPR-C expression correlates with plaque intima depth,
intimal cell-type, and severity and morphology of carotid atheroma.
Methods
Patients
Eighteen patients with high-grade, >70% stenosis, of the proximal
internal carotid artery underwent an open surgical CEA procedure at
Washington University School of Medicine-affiliated Barnes-Jewish
Hospital. Patient demographics are reviewed in Table 1. Patient CEA
plaque was removed en-bloc from the extra-cranial carotid artery
bifurcation in the operating room. Specimens were obtained for
subsequent analysis under an Institutional Review Board-approved
vascular surgery tissue banking protocol.
Demographic % (n)




Gender, Female 11 (2)
Diabetic 33 (6)
Table 1: Basic patient demographics.
CEA tissue processing
CEA specimens were transported immediately following excision to
the laboratory for analysis using two different gross sectioning
techniques. In five CEA specimens, the plaque was divided into
segments of either gross maximal disease (typically the segment of
plaque at the carotid bifurcation), and gross minimal disease (the
segment of plaque at the distal CEA edge of the internal carotid
artery). In the remaining 13 CEA specimens, gross sections were
obtained at 2-3 mm transverse intervals, and the segments with the
greatest bulk of disease were selected from each patient for further
analysis.
All plaque segments harvested for analysis were fixed in 10%
formaldehyde/0.1 M PBS (pH 7.4) for 3 hours, and dehydrated in a
series of graded alcohol washes. Following standard paraffin
embedding, 5 μm tissue sections were cut and several sections were
collected in serial 200 μm steps for immunohistochemistry (IHC) as
well as staining with hematoxylin and eosin (H&E) or Verhoeff van
Gieson (VVG) elastin stain.
CEA plaque IHC for NPR-C
Antigen retrieval was performed by treating CEA sample sections
with 1 mM ETDA at 95ºC for 10 min followed by 15 min in 1% H202 in
PBS to quench endogenous peroxidase activity. Samples were then
blocked with 2% goat serum in PBS for 20 min at room temperature
and incubated with a primary anti-human NPR-C antibody (ab97389,
Abcam, Cambridge, MA) diluted 1:1000 in PBS containing 0.05%
Tween 20 and 1% goat serum overnight at 4ºC. Avidin/Biotin blocking
was incorporated into the serum block and primary antibody steps
following manufacturer instructions (Vector Laboratories, Burlingame,
CA). The sections were then incubated with a biotinylated goat anti-
rabbit secondary antibody at a 1:200 dilution (Vector Laboratories,
Burlingame, CA) in PBS containing 0.05% Tween 20 for 30 min
followed by ABC reagent (Vector Laboratories, Burlingame, CA) for 30
min. Vector DAB substrate was used for staining sections for 60 sec.
Control sections with only 1% goat serum in place of the primary
antibody were run concurrently with the NPR-C stained slides. An
additional negative control using polyclonal rabbit IgG antibody
diluted to the same concentration as the diluted rabbit anti-human
NPR-C primary antibody (1 µg/ml) was also used.
IHC for NPR-C co-localization with VSMCs and
macrophages
Co-localization assessments of NPR-C tissue expression and intra-
plaque VSMCs and macrophages were performed according to the
manufacturer instructions for multiple antigen labeling and staining.
Sections were first stained for NPR-C with DAB as described above. In
the same tissue sections, VSMCs were then labeled using a 1:750
dilution of anti-α-actin primary antibody (clone 1A4, Sigma-Aldrich,
St. Louis, MO) for 30 min at room temperature. Macrophages were
labeled using a 1:100 dilution of anti-human macrophage CD68
primary antibody (clone KP1, Abcam, Cambridge, MA). A
biotinylated secondary antibody kit containing alkaline phosphatase
(Vectastain ABC-AP mouse IgG, AK-5002, Vector Laboratories;
Burlingame, CA) was used to counter-stain immuno-labeled VSMCs
and macrophages.
CEA specimen histology
Representative H&E and VVG stained sections were obtained from
the same CEA specimens that underwent NPR-C IHC. A separate
panel of two pathologists and one vascular biologist, blinded to the
NPR-C scoring (see below), graded tissue sections according to the
American Heart Association (AHA) classification for atherosclerosis,
I) intimal thickening, II) fatty streak, III) preatheroma, IV) atheroma,
and V) fibroatheroma [21]. AHA grade VI (complicated lesion due to
fissure, hemorrhage, or thrombus) was excluded since it was not
possible to rule out whether these plaque features resulted from plaque
manipulation during the endarterectomy procedure. Features that can
influence plaque vulnerability (plaque shoulder inflammation and
plaque calcification) were also evaluated [22,23].
Grading of NPR-C IHC
Expression of NPR-C in CEA specimens was analyzed using two
IHC grading techniques. For the five CEA specimens stratified by gross
maximal and minimal disease, a panel of blinded experts graded NPR-
C tissue staining. Five 100X random fields were randomly selected in
the superficial intima (intima <200 µm depth from the vessel lumen),
deep intima (intima >200 µm depth from the vessel lumen) [24] and
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media of the specimens. NPR-C positive cells were counted in each
field, and an average was derived for the five fields analyzed.
For the remaining 13 CEA specimens, tissue sections were analyzed
in a blinded cross-over fashion with one panel of experts grading NPR-
C expression, and a separate panel that is blinded to NPR-C scoring
grading the severity of atherosclerosis as described above.
Intima NPR-C tissue-staining intensity was graded from 0 to 4 using
a standardized scoring scale (Figure 1). A total of 54 sections were
graded from specimens of different AHA grade atheroma’s (I=3, II=2,
III=8, IV=1 and V=39).
Depending on the CEA lumen size, each plaque section required 4
to 20, 100x images to encircle the entire vessel lumen for a
corresponding total of 493 analyzed images. The internal elastic lamina
was localized with VVG staining, and was used to guide NPR-C
assessments in the CEA superficial and deep intima.
Figure 1: NPR-C grading scheme. (A) A low power (20x) image
stained with VVG showing the whole CEA. (B-F) 100x microscopic
images (inserts from A) were randomly selected around the
vascular lumen and are shown here to demonstrate the NPR-C
grading scheme. Vascular media and neointima >200 µm beyond
the vessel lumen were cropped prior to grading. (B) Example of a
grade 0 field (no too few NPR-C stained cells; (C) grade 1 field
(scattered + cells, “light staining”); (D) grade 2 field (few + cells,
light staining); (E) grade 3 field (moderate number of + cells, light
to moderate intensity); (F) grade 4 field (moderate to large number
of + cells, moderate to high stain intensity). No counterstain was
used for graded IHC slides. *Marks the vessel lumen.
Data and statistical analysis
Mean NPR-C expression scores were derived from the analyses of
blinded observers. For plaque atheromas and fibroatheromas (AHA
grades IV and V), NPR-C expression scores were derived at the plaque
shoulder and cap.
Statistical analyses were performed using SPSS software (Chicago,
IL). Linear regression analysis was used to determine the relationship
between mean NPR-C grade and plaque pathologic features of interest
(presence of atheroma/fibroatheroma, plaque hemorrhage/rupture,
shoulder inflammation, calcification within 400 µm of vessel lumen,
plaque cellularity, etc.).
Model explanatory power was assessed using adjusted R-squared for
both models. We used adjusted Cohen’s Kappa to assess the inter-rater
reliably of the IHC grading panel. Agreement was defined as ± 1 point
on the 0 to 4 grading scheme. An alpha of 0.05 was used for all tests of
significance (P<0.05).
Results
Correlation of NPR-C expression with extent of carotid
artery disease
We initially evaluated NPR-C expression in maximally and
minimally diseased CEA specimens in a cohort of 5 patients (mean age
68.8 years, 4 male) who were non-diabetic and had high-grade
asymptomatic carotid artery stenosis.
Consistent with prior findings [20] whole-mount IHC
demonstrated avid and diffuse NPR-C staining in maximally diseased
CEA specimens (Figures 2A-2D). Relative to minimally diseased
segments, maximally diseased segments had an overall 65% increase in
NPR-C tissue staining (p=0.06; Figure 2D).
Sub-layer analysis of the juxta-luminal intima demonstrated a 139%
increase in NPR-C staining in the deep intima layer of maximally
diseased carotid artery segments (p=0.05; Figures 2C and 2E). There
were also specific foci of intense NPR-C staining in the superficial
intima plaque layers of maximally diseased segments (p=0.17; Figures
2A, 2B and 2D).
Overall, we observed relatively less NPR-C expression in the media
(M) layer of maximally and minimally diseased segments, with only a
modest increase of NPR-C expression in the maximally diseased
segments (66%; p=0.2; Figures 2C and 2E).
Analysis of NPR-C relative to plaque vulnerability features
CEA specimen sections from an additional cohort of 13 patients
(mean age 64.5 years, 12 male, and 6 diabetic), were analyzed for NPR-
C plaque intima expression relative to plaque pathology, calcification,
and cell density.
CEA intima morphologic characteristics revealed a notable
incidence of plaque intima high cellularity (75.4%), thickened surface
neointima (42.3%), and an intima plaque cap (33.7%; Table 2).
Adjusted Cohen’s Kappa for inter-rater reliability for the seven-
member panel that evaluated carotid plaque histology was 0.82.
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Figure 2: NPR-C is differentially expressed in the deep intima of
maximally diseased CEA segments. (A) Representative 10x
maximally diseased carotid endarterectomy segment demonstrating
avid NPR-C staining in the intima layers. (B & C) 100x
magnifications (inserts from A) showing superficial intima (SI) and
deep intima (DI) layers, respectively. White arrows identify internal
elastic lamina separating the intima and media layers. Black arrows
identify foci of high NPR-C staining. (D) Maximally diseased CEA
specimens showed a 65% increase in NPR-C tissue staining
compared to minimally diseased segments (n=5; p=0.06). (E) The
SI, DI, and media (M) layers of maximally diseased CEA specimens
also demonstrated higher levels of NPR-C staining (139% increase
in the DI; p=0.05). *Marks the vessel lumen.
Vessel/lesion Location % (n)
Normal intima 8.0 (39)
Thickened neointima 42.3 (207)
Plaque shoulder 15.8 (77)
Plaque cap 33.7 (164)
Surgical margin 21.1 (103)
Perpendicular tear 18.9 (92)
High Cellularity 75.4 (367)
Calcification 17.0 (83)
% and n of 493 analyzed images
Table 2: Basic characteristics observed in 100x images.
A multiple linear regression model demonstrated a statistically
significant correlation between plaque severity features and mean
NPR-C score within each 100x magnification image (F=10.0, df=337,
p<0.001) with an adjusted R-squared of 0.13 (Table 3). Significant
predictors of high NPR-C expression included areas of high cell
density (β=0.315, 95% CI=0.35, 0.595) and in plaque shoulder or cap
(β=1.41, 95% CI=1.25, 1.56). Areas of high cell density within plaques
also demonstrated increased VSMC density (Figure 3). Areas of
increased plaque calcification did not have a higher grade of NPR-C
staining (Table 3). Areas in the plaque that were adjacent to the CEA
incision (longitudinal plaque transection perpendicular to the vessel
lumen) were also not significant predictors of local NPR-C expression.
Figure 3: NPR-C co-localization with VSMCs and macrophages.
NPR-C (brown) co-localized to macrophages (red) with a primary
antibody against CD-68 in an area of (A) subcapsular macrophages
and lipid core, and (B) an area of macrophages deep within a lipid
core. (C & D) α-actin staining revealed NPR-C co-localized with
VSMCs (red) in the neointima. Staining controls include (E)
staining for NPR-C alone, and (F) negative control using only
polyclonal rabbit IgG. *Marks the vessel lumen.
Variable Coef. S.E. 95% CI p
Shoulder or cap 1.406 0.079 1.251, 1.561 <0.001
High cellularity 0.315 0.142 0.35, 0.595 0.027
Surgical margin -0.052 0.131 -0.311, 0.203 0.681
Perpendicular tear 0.143 0.143 -0.138, 0.423 0.319
Nearby calcification 0.307 0.211 -0.108, 0.721 0.146
Constant 1.406 0.079 1.251, 1.561 <0.001
Coef: Coefficient; SE: Standard Error; CI: Confidence Interval
Table 3: Multiple linear regression model of local factors predicting the
NPR-C grade in each 100x image.
We further evaluated whether plaque NPR-C staining scores were
predictive of plaque AHA grade and other morphologic features. We
observed in our analysis model that NPR-C tissue expression scores
highly correlated with overall plaque AHA grade (F=3.29, df=53,
p=0.012; with an adjusted R-squared of 0.18).
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NPR-C expression was increased in the superficial intima of
atheromas and fibroatheromas, and was a significant predictor of
advanced plaque pathology (β=1.04, 95% CI=0.46, 1.64; Table 4).
However, the presence of hemorrhage, calcification, and shoulder
inflammation in the entire plaque were not significant predictors of
NPR-C expression within the superficial intima (at 200 µm depth from
the vessel lumen).
Variable Coef. S.E. 95% CI p
AHA grade IV or V 0.990 0.290 0.393, 1.587 0.002
Shoulder inflammation 0.110 0.297 -0.367, 0.586 0.645
Hemorrhage -0.015 0.221 -0.460, 0.430 0.945
Calcification -0.159 0.250 -0.661, 0.344 0.529
Constant 1.103 0.230 0.541, 1.564 <0.001
Coef., coefficient; S.E., standard error; CI, confidence interval
Table 4: Multiple linear regression model of histology features
predicting the mean NPR-C grade in each section.
Co-localization analysis of NPR-C
The majority of CD68 positive macrophages in analyzed specimens
were in the deep intima (>200 µm from the vessel lumen) and
demonstrated moderate NPR-C staining (Figures 3A and 3B). We
observed high levels of NPR-C tissue staining within the neointima
and α-actin positive VSMCs (Figures 3C and 3D). NPR-C expression
levels were approximately proportional to the number of VSMCs
observed in the intima layers analyzed. NPR-C was not identified in
superficial intima endothelial cells at image magnifications analyzed.
Areas of intima calcification, identified with H&E staining, were
distributed unevenly and showed no cell nuclei and little to no NPR-C
staining.
Discussion
The majority of patients with high-grade asymptomatic carotid
arterial occlusive disease do not progress to a symptomatic status [2,4].
Despite this, current evidence-based treatment guidelines recommend
treatment for all patients with high-grade asymptomatic disease to
prevent stroke [1]. Thus, there is a clear management dilemma since
there are no methods to identify which high-grade asymptomatic
lesions are at higher risk of causing stroke. To answer this issue, efforts
are directed to identify carotid plaque biomarkers associated with
vulnerable and advanced carotid plaque pathology [6]. This study
builds on previous findings that demonstrate differential expression
profiles of specific natriuretic peptides and their associated receptors in
atherosclerotic lesions [18,19], and in the media of segments of carotid
artery stenosis [17]. Here, we specifically observed that NPR-C
expression is localized primarily in the carotid plaque intima and
highly correlates with advanced carotid atherosclerotic plaque
pathology. Furthermore, our findings suggest that NPR-C expression is
specifically localized to vulnerable plaque intima regions. Therefore,
our study provides further evidence that NPR-C may serve as an
important diagnostic biomarker of advanced and increasingly
vulnerable carotid artery atherosclerotic disease.
NPR-C is the most abundantly expressed NPR [7,25], and is widely
distributed in various cell types such as platelets and vascular smooth
muscle cells (VSMC) [7,25-27]. Functionally, NPR-C is implicated in
multiple cardiovascular functions, including vascular permeability
[28], cardiac conduction [29], blood pressure [30], vascular
remodeling [14], and angiogenesis [31]. In endothelial cells, NPR-C
can affect endothelin expression and secretion, which regulates intimal
permeability [32,33]. In VSMCs, NPR-C can modulate VEGF
production and in turn affect hypoxia-induced tissue remodeling and
recovery [34-36]. Whole body in vivo knockout of Npr3 (NPR-C gene)
in a murine model leads to hypotension and skeletal deformities due to
rapid bone turnover [37]. Antisense knockdown of Npr3 attenuates
CNP-mediated inhibition of cardiac chronotropic effects [38]. The
variety of reported NPR-C cellular functions highlights its multifaceted
roles in cardiovascular homeostasis.
Less is known about the role of NPR-C in cardiovascular pathology,
particularly in arterial beds affected by advanced atherosclerotic
plaque. In human coronary atherosclerotic lesions, NPR-C and NPR-B
but not NPR-A, have increased expression in the intima and inner
medial layers [7]. Expression levels of NPR-C and its ligands are
dependent on the type of lesion, and appear to have the highest
intensity expression in intermediate-type plaques [17]. A continuous
infusion of the potent NPR-C ligand, CNP, can inhibit intimal
proliferation in rat common carotid arteries following an induced
intimal injury [18]. NPR-C and CNP expression is up-regulated in the
neointima of rat carotid arteries 14 days after balloon angioplasty [39].
In a hypercholesterolemic rabbit model, both NPR-C and its CNP
ligand were found to be expressed in intraluminal plaques and in
neointimal VSMCs [18].
Kuehnl et al. also demonstrated that NPR-C expression was
augmented in histologically unstable carotid artery plaques [20]. That
group reported NPR-C, NPR-B, and CNP is mostly expressed in the
VSMCs of the media. Our findings uniquely demonstrate that NPR-C
is differentially expressed in the vulnerable plaque intimal regions, and
in VSMCs that have migrated into the deep and superficial intima
layers. Relative to the intima, we observed minimal NPR-C staining in
the carotid artery media (Figure 2). Furthermore, in maximally
diseased carotid artery plaques we observed higher NPR-C expression
in the deep intima layers than in the superficial intima layers (Figure
2C). Our findings support the theory that VSMCs infiltrating into the
carotid plaque intima are pathologically unique, and have differential
expression of NPR-C relative to plaque severity. We suspect that
increased NPR-C expression in progressive atheroma contributes to
altered autocrine/paracrine signaling in the plaque microenvironment
that affects VSMC migration and function.
We also demonstrate moderate NPR-C co-localization with intima
macrophages (Figure 3). Prior studies also observed this in arterial
walls undergoing rapid remodeling [40]. For example, Naruko et al.
reported increased NPR-C expression in the neointima following intra-
arterial balloon angioplasty [12]. In our study, the majority of
macrophages that were positive for NPR-C were in the deep intima
(>200 µm from the lumen), where we also observed notable VSMC
staining and co-localization (Figure 3). This suggests that this deep
intima plaque region is a uniquely active layer with variable NPR-C
expression and cellular composition. We also observed fewer NPR-C
positive macrophages at plaque shoulder regions. This may help
explain why plaque shoulder inflammation was not found to be a
significant predictor of NPR-C expression in our overall regression
analysis. It also demonstrates that not all areas of macrophage
accumulation are necessarily associated with high NPR-C expression,
and differential expression of NPR-C is not exclusive to macrophage
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density. Thus, plaque intima expression of NPR-C is affected by
multiple cell types that work in concert with one another to affect
plaque progression and vulnerability.
Non-invasive in vivo positron emission tomography (PET)-
mediated molecular imaging can specifically localize NPR-C
expression in the lumen arterial wall [41]. We recently developed a
unique multifunctional, PET-compatible 64Cu-radiolabeled, core-shell
nanoparticle that can specifically bind to NPR-C in vivo [42]. This
technology is transferable in the diagnosis and management of patients
with advanced asymptomatic carotid artery atherosclerosis. Non-
invasive molecular imaging of NPR-C and other biomarkers of
advanced and vulnerable disease can help identify patients who are at
higher risk of a stroke, and can justify earlier and/or more targeted
intervention. A feasibility clinical trial is currently underway to
evaluate the safety and efficacy of molecular imaging of NPR-C in
patients with advanced carotid artery stenosis (PET Imaging of
Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis;
NCT02417688) [43].
In conclusion, we show that NPR-C expression is increased in the
intima of human CEA plaques. We further demonstrate that in the
intima, NPR-C expression co-localizes to VSMCs and macrophages
that reside in the deep plaque intima layer. Our findings suggest that
NPR-C expression correlates with advanced disease and vulnerable
plaque features. This suggests that NPR-C is a potentially important
biomarker of unstable atherosclerotic lesions particularly in the carotid
arterial system. Accordingly, NPR-C molecular imaging may be useful
in risk-stratification of patients with asymptomatic advanced carotid
artery atherosclerotic disease.
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